Polpharma Biologics, the biopharmaceutical division of Polpharma Group, is pleased to introduce a new website highlighting our end-to-end capabilities in the development and manufacture of biologics and biosimilars.
In addition to providing in-depth information on our world-class expertise and facilities, the new website serves to further define our position as both a one-stop-shop CDMO and innovator of our own novel biologics and biosimilars.
Polpharma Biologics is one of the few fully integrated CDMOs supporting the development of biologic products, and we look forward to using this platform to share relevant, insightful content to help visitors better understand the biopharmaceutical landscape. This includes thought leadership articles, white papers, news and more.
We hope you will take the opportunity to look around the site and discover everything Polpharma Biologics has to offer.